Exagen Inc.: Canaccord Genuity raises target price to $11 from $9
XGN•Canaccord Genuity raised its target price for Exagen Inc. to $11 from $9.
Related News
WaFd Inc: KBW cuts target price to $34 from $40
WAFD•
Spanish stocks - Factors to watch on Oct 19
SAN•
FirstEnergy: JP Morgan cuts target price to $50 from $52
FE•
Infleqtion hosts first quantum application forum on commercial uses
INFQ•
HA Sustainable Infrastructure Capital, Inc.: JPMorgan cuts target price to $45 from $51
HASI•